243 related articles for article (PubMed ID: 17572502)
1. Cefotaxime-resistant Citrobacter freundii in isolates from blood in a tertiary teaching hospital in Northern Taiwan.
Liu CP; Weng LC; Tseng HK; Wang NY; Lee CM
J Infect; 2007 Oct; 55(4):363-8. PubMed ID: 17572502
[TBL] [Abstract][Full Text] [Related]
2. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.
Chen S; Hu F; Liu Y; Zhu D; Wang H; Zhang Y
Am J Infect Control; 2011 Nov; 39(9):e55-60. PubMed ID: 21705111
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
Park YJ; Yu JK; Lee S; Oh EJ; Woo GJ
J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
[TBL] [Abstract][Full Text] [Related]
4. Emergence of cefotaxime resistance in Citrobacter freundii causing necrotizing fasciitis and osteomyelitis.
Chuang YM; Tseng SP; Teng LJ; Ho YC; Hsueh PR
J Infect; 2006 Sep; 53(3):e161-3. PubMed ID: 16375973
[TBL] [Abstract][Full Text] [Related]
5. Citrobacter freundii bacteremia: Risk factors of mortality and prevalence of resistance genes.
Liu LH; Wang NY; Wu AY; Lin CC; Lee CM; Liu CP
J Microbiol Immunol Infect; 2018 Aug; 51(4):565-572. PubMed ID: 28711438
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to cefotaxime, ceftazidime, cefepime and aztreonam.
Cheng NC; Liu CY; Huang YT; Liao CH; Teng LJ; Hsueh PR
J Antimicrob Chemother; 2012 Jun; 67(6):1413-21. PubMed ID: 22345386
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
Yang H; Chen H; Yang Q; Chen M; Wang H
Antimicrob Agents Chemother; 2008 Dec; 52(12):4268-73. PubMed ID: 18809939
[TBL] [Abstract][Full Text] [Related]
8. Plasmid-mediated quinolone resistance determinants among enterobacterial isolates from outpatients in Brazil.
Minarini LA; Poirel L; Cattoir V; Darini AL; Nordmann P
J Antimicrob Chemother; 2008 Sep; 62(3):474-8. PubMed ID: 18552340
[TBL] [Abstract][Full Text] [Related]
9. Citrobacter infections in a tertiary care hospital in Northern India.
Mohanty S; Singhal R; Sood S; Dhawan B; Kapil A; Das BK
J Infect; 2007 Jan; 54(1):58-64. PubMed ID: 16815552
[TBL] [Abstract][Full Text] [Related]
10. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and characteristics of aac(6')-Ib-cr in AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens: a multicenter study from Korea.
Kim SY; Park YJ; Yu JK; Kim YS; Han K
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):314-8. PubMed ID: 19216942
[TBL] [Abstract][Full Text] [Related]
12. First detection of a VIM-1 metallo-beta-lactamase in a carbapenem-resistant Citrobacter freundii clinical isolate in an acute hospital in Germany.
Weile J; Rahmig H; Gfröer S; Schroeppel K; Knabbe C; Susa M
Scand J Infect Dis; 2007; 39(3):264-6. PubMed ID: 17366062
[TBL] [Abstract][Full Text] [Related]
13. Partial characterisation of the acrAB locus in two Citrobacter freundii clinical isolates.
Sánchez-Céspedes J; Vila J
Int J Antimicrob Agents; 2007 Sep; 30(3):259-63. PubMed ID: 17631985
[TBL] [Abstract][Full Text] [Related]
14. Detection of KPC-2-producing Citrobacter freundii isolates in Spain.
Gómez-Gil MR; Paño-Pardo JR; Romero-Gómez MP; Gasior M; Lorenzo M; Quiles I; Mingorance J
J Antimicrob Chemother; 2010 Dec; 65(12):2695-7. PubMed ID: 20851814
[No Abstract] [Full Text] [Related]
15. Boronic acid disk tests for identification of extended-spectrum beta-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC beta-lactamases.
Jeong SH; Song W; Park MJ; Kim JS; Kim HS; Bae IK; Lee KM
Int J Antimicrob Agents; 2008 May; 31(5):467-71. PubMed ID: 18337065
[TBL] [Abstract][Full Text] [Related]
16. Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012.
Gaibani P; Ambretti S; Farruggia P; Bua G; Berlingeri A; Tamburini MV; Cordovana M; Guerra L; Mazzetti M; Roncarati G; Tenace C; Moro ML; Gagliotti C; Landini MP; Sambri V
Int J Infect Dis; 2013 Sep; 17(9):e714-7. PubMed ID: 23528638
[TBL] [Abstract][Full Text] [Related]
17. Two chromosomally located qnrB variants, qnrB6 and the new qnrB16, in Citrobacter spp. isolates causing bacteraemia.
Sanchez-Cespedes J; Marti S; Soto SM; Alba V; Melción C; Almela M; Marco F; Vila J
Clin Microbiol Infect; 2009 Dec; 15(12):1132-8. PubMed ID: 19392890
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility and multiplex PCR screening of AmpC genes from isolates of Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens.
Kao CC; Liu MF; Lin CF; Huang YC; Liu PY; Chang CW; Shi ZY
J Microbiol Immunol Infect; 2010 Jun; 43(3):180-7. PubMed ID: 21291844
[TBL] [Abstract][Full Text] [Related]
19. Bacteraemia caused by non-freundii, non-koseri Citrobacter species in Taiwan.
Lai CC; Tan CK; Lin SH; Liu WL; Liao CH; Huang YT; Hsueh PR
J Hosp Infect; 2010 Dec; 76(4):332-5. PubMed ID: 20708303
[TBL] [Abstract][Full Text] [Related]
20. Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: emergence of Citrobacter freundii as a common microorganism.
Khorasani G; Salehifar E; Eslami G
Burns; 2008 Nov; 34(7):947-52. PubMed ID: 18378087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
